Alector (ALEC) Invested Capital (2025 - 2026)

Alector's (ALEC) quarterly Invested Capital came in at $1.5 million in Q1 2026, up 304.37% on a QoQ basis from $366000.0 in Q4 2025.

Alector (ALEC) Invested Capital (2025 - 2026) Analysis & Trends

Alector (ALEC) has 2 years of Invested Capital data on file, last reported at $1.5 million in Q1 2026.

  • On a quarterly basis, Invested Capital changed N/A year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $366000.0, changed N/A from the prior year.
  • Invested Capital for Q1 2026 stood at $1.5 million, up from $366000.0 in the prior quarter.
  • Over the last five years, Invested Capital for ALEC reached as high as $1.5 million in Q1 2026 and fell as low as $366000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.96 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 116.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Alector 164.78 Mn -41.74 Mn - 1.48 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.48 Mn
Dec 31, 2025 366,000.00